End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.688 EUR | -4.44% | -18.48% | -76.28% |
05-15 | Acticor: 'new perspectives' in stroke treatment | CF |
05-15 | Acticor Biotech Announces Presentation of the Main Results of the Phase 2/3 Actisave Study in the Treatment of Stroke at ESOC 2024 | CI |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
9.8M | - | - | - | - | - | |
118B | ||||||
106B | ||||||
24.28B | - | |||||
21.96B | - | |||||
18.16B |